O-13 Factors impacting unbound vancomycin concentrations in neonates and young infants
Sign Up to like & getrecommendations! Published in 2017 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2017-esdppp.13
Abstract: Background Vancomycin, a glycopeptide, is often ad-ministered to treat (suspected) serious gram-positive in-fections caused by Staphylococci, including methicillin-re-sistant Staphylococcus aureus (MRSA) and coagulase-neg-ative Staphylococci (CoNS). Vancomycin pharmacokinetic (PK) and pharmacodynamic (PD) data in neonates are… read more here.
Keywords: vancomycin; vancomycin concentration; neonates young; young infants ... See more keywords